N-Nitroso Nortriptyline D3 | N-Nitroso Amitriptyline EP Impurity C-D3
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. N-Nitroso Nortriptyline D3can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines . N-Nitroso Nortriptyline D3 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline D3 CAS NO:NA is also known as N-Nitroso Amitriptyline EP Impurity C-D3 Chemically represented as N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-(methyl-d3)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline D3. We supply N-Nitroso Nortriptyline D3 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014998 |
| CAS No | NA |
| Mol.F. | C15H22N4O2 |
| Mol.Wt. | 290.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014999 |
| CAS No | NA |
| Mol.F. | C15H17N5O4 |
| Mol.Wt. | 331.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141000 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O6S |
| Mol.Wt. | 567.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141001 |
| CAS No | NA |
| Mol.F. | C26H31F2N7O5S |
| Mol.Wt. | 591.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141002 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141003 |
| CAS No | NA |
| Mol.F. | C23H28FN7O5S |
| Mol.Wt. | 533.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141004 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141005 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141006 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141007 |
| CAS No | NA |
| Mol.F. | C25H29F2N7O6S |
| Mol.Wt. | 593.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141008 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O5S |
| Mol.Wt. | 407.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141009 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141010 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O6S |
| Mol.Wt. | 423.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141011 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141012 |
| CAS No | NA |
| Mol.F. | C15H22ClN5O6S |
| Mol.Wt. | 435.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141013 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |